Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company
What long-term size projections exist for the Infectious Disease In Vitro Diagnostics Market covering 2026–2035?
The infectious disease in vitro diagnostics market has seen robust expansion over recent years. It is anticipated to expand from $15.1 billion in 2025 to $16.13 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.8%. The historical rise can be credited to the global impact of infectious diseases, the enlargement of hospital laboratories, the necessity for early detection, innovations in immunoassays, and government-led disease control programs.
The infectious disease in vitro diagnostics market is anticipated to experience robust expansion over the coming years. This market is projected to reach $21.25 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.1%. Several factors will contribute to this growth during the forecast period, including pandemic preparedness initiatives, an increase in molecular diagnostics, growing antimicrobial resistance, the expansion of diagnostic laboratories, and enhanced healthcare screening. Key trends shaping the forecast period encompass the swift adoption of molecular diagnostics, point-of-care infectious testing, detection of pathogens with high sensitivity, the use of multiplex diagnostic panels, and expanded surveillance testing.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=30303&type=smp
Which Drivers Are Impacting The Competitive Landscape Of The Infectious Disease In Vitro Diagnostics Market?
The infectious disease in vitro diagnostics market experienced growth during the historic period, primarily fueled by the escalating global prevalence of infectious diseases. These infectious diseases encompass individuals worldwide affected by bacterial, viral, fungal, or parasitic infections at a specific point in time, indicating the total disease burden within populations. Climate change has further expanded the habitats of disease-carrying vectors such as mosquitoes, contributing to an increase in the global prevalence of infectious diseases. Infectious disease in vitro diagnostics support this trend by providing precise and timely diagnostic tools, which enable healthcare providers to identify pathogens, initiate appropriate treatment, and contain outbreaks more effectively. For instance, in October 2024, the World Health Organization, a Switzerland-based health authority, reported that approximately 10.8 million people worldwide contracted tuberculosis, with 55% being men, 33% women, and 12% children and adolescents, and individuals living with human immunodeficiency virus (HIV) representing 6.1% of cases. Therefore, the increasing global prevalence of infectious diseases fueled the growth of the infectious disease in vitro diagnostics market during the historic period.
What Segments Are Identified Within The Structure Of The Infectious Disease In Vitro Diagnostics Market?
The infectious disease in vitro diagnostics market covered in this report is segmented –
1) By Product Type: Instruments, Reagents, Software And Services
2) By Technology: Molecular Diagnostics, Immunoassay, Microbiology
3) By Application: Methicillin-Resistant Staphylococcus Aureus (MRSA), Clostridium Difficile, Respiratory Virus, Tuberculosis (TB) And Drug-Resistant Tuberculosis (TB), Gonorrhea, Human Papillomavirus (HPV), Human Immunodeficiency Virus (HIV), Hepatitis C, Hepatitis B, Other Applications
4) By End-Use: Hospitals And Clinics, Diagnostic Laboratories, Other End-Users
Subsegments:
1) By Instrument: Polymerase Chain Reaction Machines, Immunoassay Analyzers, Microbiology Analyzers, Next Generation Sequencers
2) By Reagent: Molecular Reagents, Immunoassay Reagents, Microbiology Reagents, Enzymes And Buffers, Controls And Calibrators
3) By Software And Services: Data Management Software, Laboratory Information Systems, Cloud Based Solutions, Maintenance And Support Services, Consulting And Training Services
Which Innovation Trends Are Advancing Developments Within The Infectious Disease In Vitro Diagnostics Market?
Leading companies within the infectious disease in vitro diagnostics market are concentrating on developing innovative products, such as systems for the rapid identification of multiple gastrointestinal pathogens. This focus aims to facilitate prompt diagnosis, enhance patient outcomes, and expand capabilities for point-of-care testing. The rapid detection of multiple gastrointestinal pathogens involves diagnostic tests capable of swiftly identifying several disease-causing microorganisms within the gastrointestinal tract using a single sample. As an example, in June 2024, MP Biomedicals, a US-based supplier of various products, chemicals, and diagnostics, introduced a new series of immunochromatographic rapid diagnostic kits designed for gastrointestinal infectious diseases. These kits facilitate the swift and precise detection of Helicobacter pylori, Salmonella typhi, and Vibrio cholerae serogroups O1 and O139. Key characteristics of these kits include rapid, qualitative detection at the point of care, adaptability for various sample types (stool, blood, plasma, serum, water, and food), and applicability in both clinical and research environments. Utilizing advanced immunochromatographic technology, they contribute to early diagnosis, effective treatment monitoring, and verification of pathogen eradication, marking a notable progression in gastrointestinal health diagnostics by integrating speed, accuracy, and extensive pathogen identification.
Which Major Firms Are Strengthening Their Position In The Infectious Disease In Vitro Diagnostics Market?
Major companies operating in the infectious disease in vitro diagnostics market are F. Hoffmann-La Roche AG, Abbott Laboratories, Danaher Corporation, Thermo Fisher Scientific Inc., Siemens Healthcare AG, bioMérieux SA, QIAGEN N.V., Becton Dickinson and Company, Hologic Inc., DiaSorin S.p.A., Meridian Bioscience, Quidel Corporation, Revvity Inc., OraSure Technologies Inc., Transasia Bio-Medicals Ltd., Randox Laboratories, Luminex Corporation, Wako Pure Chemical Industries Ltd., Bio-Rad Laboratories Inc., Trivitron Healthcare
Access The Complete Report For Deeper Market Insights:
Which Regions Are Poised For Strategic Growth In The Infectious Disease In Vitro Diagnostics Market?
North America was the largest region in the infectious disease in vitro diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease in vitro diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Infectious Disease In Vitro Diagnostics Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=30303&type=smp
Browse Through More Reports Similar to the Global Infectious Disease In Vitro Diagnostics Market 2026, By The Business Research Company
Cogeneration Equipment Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/cogeneration-equipment-global-market-report
Sterilization Equipment Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/sterilization-equipment-global-market-report
Respiratory Devices And Equipment Global Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company